Detalhe da pesquisa
1.
Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study.
Cardiovasc Diabetol
; 22(1): 175, 2023 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37438827
2.
Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillationã- ANAFIE Registry Sub-Analysis.
Circ J
; 87(12): 1765-1774, 2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482411
3.
Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillationã- Results From the ANAFIE Registry.
Circ J
; 87(7): 957-963, 2023 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653127
4.
Echocardiographic Parameters of Left Atrial Structure and Function and Clinical Outcomes at 2 Years in Elderly Patients With Atrial Fibrillationã- The ANAFIE Echocardiographic Substudy.
Circ J
; 2023 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899253
5.
Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry.
Stroke
; 53(8): 2549-2558, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440169
6.
Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillationã- A Sub-Analysis of the ANAFIE Registry.
Circ J
; 87(1): 6-16, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858804
7.
Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats.
J Thromb Thrombolysis
; 52(1): 9-17, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534029
8.
Effects of concomitant use of prasugrel with edoxaban on bleeding time, pharmacodynamics, and pharmacokinetics of edoxaban in healthy elderly Japanese male subjects: a clinical pharmacology study.
Thromb J
; 18: 10, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32536828
9.
Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis.
J Thromb Thrombolysis
; 49(1): 94-99, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396790
10.
Association between plasma concentration of edoxaban determined by direct and indirect methods in Japanese patients with non-valvular atrial fibrillation (CVI ARO 7).
Heart Vessels
; 35(3): 409-416, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522245
11.
Exploratory Analysis of Circulating miRNA Signatures in Atrial Fibrillation Patients Determining Potential Biomarkers to Support Decision-Making in Anticoagulation and Catheter Ablation.
Int J Mol Sci
; 21(7)2020 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32244749
12.
Sensory evaluation of edoxaban orally disintegrating tablets: an open-label interventional study (secondary publication).
Thromb J
; 17: 3, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30814914
13.
A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
J Thromb Thrombolysis
; 48(1): 103-110, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972711
14.
Responses of prothrombin time and activated partial thromboplastin time to edoxaban in Japanese patients with non-valvular atrial fibrillation: characteristics of representative reagents in Japan (CVI ARO 7).
Heart Vessels
; 34(12): 2011-2020, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123819
15.
Prevention of Stent Thrombosis in Rats by a Direct Oral Factor Xa Inhibitor Edoxaban.
Pharmacology
; 103(1-2): 17-22, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30343300
16.
A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.
J Thromb Thrombolysis
; 46(1): 95-101, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29704172
17.
Generation and characterization of tissue-type plasminogen activator transgenic rats.
J Thromb Thrombolysis
; 45(1): 77-87, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168147
18.
Correction to: Generation and characterization of tissue-type plasminogen activator transgenic rats.
J Thromb Thrombolysis
; 45(1): 88, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29249040
19.
Correction: Responses of prothrombin time and activated partial thromboplastin time to edoxaban in Japanese patients with non-valvular atrial fibrillation: characteristics of representative reagents in Japan (CVI ARO 7).
Heart Vessels
; 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015233
20.
Correction: Association between plasma concentration of edoxaban determined by direct and indirect methods in Japanese patients with non-valvular atrial fibrillation (CVI ARO 7).
Heart Vessels
; 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015234